Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.33 |
| ▸ | HTT | P42858 | 6/20 | 0.32 |
| ▸ | USP2 | O75604 | 4/20 | 0.32 |
| ▸ | NPC1 | O15118 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 3/20 | 0.32 |
| ▸ | RECQL | P46063 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | INMT | O95050 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23661070 | 1.00 | MAPT (0.37) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL497532 | 0.97 | MAPT (0.38) | MAPTALDH1A1LMNAHPGDCHKA | |
| SCHEMBL497507 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL8420655 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL8992014 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL23661069 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL6699994 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL23486255 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL11110396 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 | |
| SCHEMBL14818806 | 0.93 | ALDH1A1 (0.35) | MAPTALDH1A1LMNAHTTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023098640-A1 | PREPARATION METHOD FOR DRUG INTERMEDIATE | 浙江华海药业股份有限公司 | 2023-06-08 | — | — | WO | disclosed |
| US-20210221776-A1 | PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-07-22 | — | — | US | disclosed |
| WO-2021012671-A1 | HIGHLY EFFICIENT PREPARATION METHOD FOR PROGESTERONE WITH LOW POLLUTION | 浙江神洲药业有限公司 | 2021-01-28 | — | — | WO | disclosed |
| WO-2013177708-A1 | BORENIUM FRUSTRATED LEWIS PAIR CATALYSTS | STEPHAN CONSULTING CORPORATION (CA) | 2013-12-05 | — | — | WO | disclosed |
| CN-102224105-B | Method for preparing ssz-26/33 zeolites using novel structure directing agents | CHEVRON USA INC | 2013-09-04 | — | — | CN | disclosed |
| CN-101827814-B | Novel carbamoylglycine derivatives | DSM IP ASSETS BV | 2012-11-28 | — | — | CN | disclosed |
| US-8198501-B2 | Zeolite catalyst for hydroisomerization of light paraffins to produce high octane gasoline | CHEVRON U.S.A. INC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-8119621-B2 | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-02-21 | — | — | US | disclosed |
| US-8119621-B2 | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-02-21 | — | — | US | disclosed |
| US-8119621-B2 | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-02-21 | — | — | US | disclosed |
| US-20070054837-A1 | Bicyclic lactones, perfumery uses thereof, processes for preparing same and intermediates therefor | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-03-08 | — | — | US | disclosed |
| US-7169747-B2 | Bicyclic lactones, perfumery uses thereof, processes for preparing same and intermediates therefor | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2007-01-30 | — | — | US | disclosed |
| US-7169747-B2 | Bicyclic lactones, perfumery uses thereof, processes for preparing same and intermediates therefor | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2007-01-30 | — | — | US | disclosed |
| US-4221800-A | ANTIALLERGENS, ANTIHISTAMINES | MILES LABORATORIES, INC. (US) | 1980-09-09 | — | — | US | disclosed |
| US-3991111-A | ANTIBIOTICS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1976-11-09 | — | — | US | disclosed |
| US-3979455-A | Preparation of dioxyimino-cycloalkanones and related intermediates | TEXACO INC. (US) | 1976-09-07 | — | — | US | disclosed |
| US-3951962-A | ANTIBACTERIAL | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1976-04-20 | — | — | US | disclosed |
| US-3948907-A | VINYL POLYMERIZATION INITIATORS | THE DOW CHEMICAL COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
| US-3948891-A | INITIATORS OF VINYL POLYMERIZATION | THE DOW CHEMICAL COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
| US-3947418-A | POLYMERIZATION INITIATORS | THE DOW CHEMICAL COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210221776-A1 | PERFLUOROAMINOOLEFINS AND METHODS OF MAKING AND USING THE SAME | FGB, RFTN1, AFF1 | MAPT 3083/4885ALDH1A1 4051/4885LMNA 1664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.